Supporting agencies: The study was financed by Farmenterprises LLC.
For citations:
Stukova М.А., Rydlovskaya A.V., Proskurina O.V., Mochalov S.V., Shurygina A.S., Nebolsin V.E. In vitro and in vivo pharmacodynamic activity of the new compound XC221GI in models of the viral inflammation of the respiratory tract. Microbiology Independent Research Journal (MIR Journal). 2022;9(1):56-70. https://doi.org/10.18527/2500-2236-2022-9-1-56-70
Views: 103
Email this article 